DNASE1L1

DNASE1L1 Full Name

deoxyribonuclease I-like 1

DNASE1L1 Introduction

DNASE1L1, officially designated as deoxyribonuclease I-like 1, is a protein‑coding gene that resides on chromosome Xq28, a region rich in immune‑related and neurological loci. This gene spans approximately 12 kilobases and comprises eight exons, with alternative splicing events generating at least two transcript variants. Its genomic position near the telomeric end of the long arm suggests potential regulatory crosstalk with neighboring genes, though its expression pattern remains relatively restricted compared to its better‑studied paralog, DNASE1. Evolutionary analysis indicates that DNASE1L1 emerged from a duplication event ancestral to mammals, and it has since acquired distinct promoter elements that drive cell‑type‑specific transcription, particularly in certain epithelial and lymphoid tissues.The translated precursor of DNASE1L1 contains 302 amino acids, including a canonical N‑terminal signal peptide that directs it toward the secretory pathway, yet many isoforms are retained intracellularly. Its core structure adopts a β‑sheet‑rich fold typical of the DNase I superfamily, stabilized by two disulfide bridges and requiring divalent cations—preferentially Ca²⁺ and Mg²⁺—for endonucleolytic activity. Key catalytic residues, including histidine and aspartate pairs within the active site, are highly conserved, but a substitution in the DNA‑binding loop reduces its affinity for double‑stranded substrates relative to DNASE1. This altered electrostatic surface may explain its preference for nicking supercoiled plasmid DNA rather than generating random double‑strand breaks, a property that distinguishes it functionally from classical apoptotic nucleases.

Figure1. Dnase1 Family in Autoimmunity.(Engavale M, McCord J, Mapp B, et al. 2021)

_{Enzymatic Activity and Substrate Preferences}
Biochemical characterization reveals that DNASE1L1 has a specific activity roughly 10‑fold weaker than pancreatic DNASE1 under physiological ionic conditions, and its pH optimum is shifted toward a mildly acidic environment (pH 6.0–6.5), aligning with the luminal milieu of secretory epithelia. It exhibits a marked preference for single‑stranded DNA and RNA‑DNA hybrids over native duplex DNA, and its endonuclease action produces 5'‑phosphorylated oligonucleotides with 3'‑hydroxyl termini. Notably, the enzyme is resistant to actin inhibition—a feature that separates it from classical DNase I—and its catalytic efficiency is enhanced by histones, suggesting a role in chromatin remodeling during epithelial turnover. These biochemical nuances imply that DNASE1L1 may function as a niche‑specific scavenger of non‑canonical nucleic acid species.

Physiological Roles and Disease Implications
Currently, no Mendelian disorder has been unequivocally linked to DNASE1L1 mutations, but emerging evidence implicates its dysregulation in inflammatory bowel disease, where reduced expression correlates with impaired mucus‑associated DNA clearance. In transgenic murine models, knockout of the orthologous gene leads to accumulation of extracellular nucleic acid aggregates in intestinal crypts, accompanied by heightened local TNF‑α signaling, yet systemic autoimmunity does not develop. Furthermore, promoter hypermethylation of DNASE1L1 has been observed in several carcinoma types, including gastric and prostate cancers, suggesting that its silencing may facilitate tumor progression by enabling persistent DNA‑mediated Toll‑like receptor activation. These observations position DNASE1L1 as a promising biomarker for mucosal homeostasis, though therapeutic targeting remains speculative without deeper mechanistic insights.

Alternate Names for DNASE1L1

DNASE1L1; deoxyribonuclease I-like 1; XIB; G4.8; DNL1L; DNASEX; DNAS1L1; deoxyribonuclease-1-like 1; DNase X; DNase I-like 1; DNase I-like, muscle-specific;

• 1.Engavale M, McCord J, Mapp B, et al. Dnase1 family in autoimmunity. Encyclopedia, 2021, 1(3): 527-541.